PORTFOLIO

PORTFOLIO COMPANIES

EditForce Inc.

  • CEO:
    Takashi Ono

URL:http://www.editforce.jp

COMPANY PROFILE

Developing novel drugs and agricultural seeds through DNA / RNA manipulation.

EditForce Inc. develops novel drugs and seeds (for agriculture) by manipulating the nucleic acids (DNA/RNA). EditForce was established by a trading company KISCO Ltd. and Takahiro Nakamura (Associate Professor at Kyushu University) in 2015, when UTEC also started supporting the company. EditForce provides a proprietary alternative option to genome editing as well as a novel tool for versatile editing of RNA molecules on a genomic scale, called ‘transcriptome editing’, based on pentatricopeptide repeat (PPR) protein engineering technologies that Dr. Nakamura invented. Dr. Nakamura studied a large family of plant-specific PPR proteins related to plant immunity and elucidated the DNA/RNA recognition mechanism of PPR proteins. He applied it to EditForce's novel genome design/programming tools in pharmaceutical and agricultural industries and so on.

COMPANY STORY

Origin

EditForce was founded based on the PPR genome editing technique (invented by Takahiro Nakamura, Associate Professor, Kyushu University), in order to revolutionize the genome editing industry (compared to the ZFN, TALEN, CRISPR techniques developed abroad) and commercialize the PPR genome editing technology.

Strength

PPR technology has the ability to recognize both DNA and RNA. It is the world's first editing tool that can edit both DNA and RNA.

UTEC value up

UTEC has introduced management executives to the company and is also helping the founders with business planning, partnerships and IPO strategies
  • DNA/RNA Modification by PPR

RELATED NEWS